Hyperfine Inc
NASDAQ:HYPR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Hyperfine Inc
Cash from Financing Activities
Hyperfine Inc
Cash from Financing Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
H
|
Hyperfine Inc
NASDAQ:HYPR
|
Cash from Financing Activities
$27.5m
|
CAGR 3-Years
1 478%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Financing Activities
-$395m
|
CAGR 3-Years
14%
|
CAGR 5-Years
-47%
|
CAGR 10-Years
N/A
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Cash from Financing Activities
-$956.8m
|
CAGR 3-Years
12%
|
CAGR 5-Years
-40%
|
CAGR 10-Years
-8%
|
|
|
Stryker Corp
NYSE:SYK
|
Cash from Financing Activities
$113m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abbott Laboratories
NYSE:ABT
|
Cash from Financing Activities
-$6.3B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-7%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Financing Activities
-$2.4B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-94%
|
CAGR 10-Years
N/A
|
|
Hyperfine Inc
Glance View
Hyperfine, Inc. is a medical device development company, which engages in providing imaging and monitoring through magnetic resonance imaging to revolutionize healthcare for people. The company is headquartered in Guilford, Connecticut and currently employs 136 full-time employees. The company went IPO on 2021-01-27. The firm provides a Swoop system, which is a portable magnetic resonance imaging (MRI) system capable of providing neuroimaging at the point of care. Its Swoop Portable Magnetic Resonance Imaging System (Swoop system) produces images at a lower magnetic field strength than conventional MRI scanners. MRI is a medical imaging technique used in radiology to image the human body’s anatomy and physiological processes. MRI is used in various clinical settings for medical diagnosis, the staging of disease, and follow-up treatment. The company designed its Swoop system to address an unmet need in point-of-care medical imaging through a combination of hardware and Artificial intelligence (AI)-powered software services. Its hardware uses modern computational power and deep learning advances. Its software addresses the traditional ease-of-use and integration challenges often presented by specialized medical technologies.
See Also
What is Hyperfine Inc's Cash from Financing Activities?
Cash from Financing Activities
27.5m
USD
Based on the financial report for Dec 31, 2025, Hyperfine Inc's Cash from Financing Activities amounts to 27.5m USD.
What is Hyperfine Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-15%
Over the last year, the Cash from Financing Activities growth was 2 599%. The average annual Cash from Financing Activities growth rates for Hyperfine Inc have been 1 478% over the past three years , -15% over the past five years .
